John Strickler, M.D.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer (NCT07224022) | John Strickler, M.D. | 2026-07-01 |
| Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer (NCT02008383) | John Strickler, M.D. | 2014-01-01 |
| Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer (NCT01661972) | John Strickler, M.D. | 2012-08-01 |
Track John Strickler, M.D. automatically
Every clearance here is in the API, with alerts when new ones post.